> Without question, a subset of the US population receives better care for non-emergency medical issues. But also without question, this improved service comes

> Without question, a subset of the US population receives better care for non-emergency medical issues. But also without question, this improved service comes with a substantial increase in cost. I'm not convinced that even this is a given: A large percentage of those costs are the result of articial inflation that benefits pharmaceutical and insurance companies tremendously, but costs the average American a fortune. A month's worth of chemotherapy in the U.S. can easily cost ten times more than the equivalent in any European country (not factoring in insurance.) The rich getting quality care never seemed a particularly convincing argument against healthcare overhaul. It's even more ridiculous when you consider that there is world-class private healthcare in Europe as well.